Old Web
English
Sign In
Acemap
>
Paper
>
An FDA perspective on antiarrhythmic drugs in phase II trials
An FDA perspective on antiarrhythmic drugs in phase II trials
2000
Raymond J. Lipicky
Keywords:
Antiarrhythmic agent
Clinical trial
Intensive care medicine
Chemotherapy
Heart disease
Medicine
Pathology
Internal medicine
Cardiology
Toxicity
food and drug administration
Diabetes mellitus
Surgery
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]